flavone has been researched along with galangin in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (42.86) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 8 (38.10) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CJ; Geahlen, RL | 1 |
| Constantinou, A; Mehta, R; Moon, R; Rao, K; Runyan, C; Vaughan, A | 1 |
| Chen, K; Cheng, YC; Hu, CQ; Kilkuskie, RE; Lee, KH; Shi, Q | 1 |
| Jacobson, KA; Ji, XD; Melman, N | 1 |
| Jacobson, KA; Ji, XD; Jiang, JL; Karton, Y; Melman, N; Olah, ME; Stiles, GL | 1 |
| Augereau, JM; Billon, M; Gleye, J; Herbert, JM; Lale, A; Leconte, M | 1 |
| Jacobson, KA; Moro, S; Sanders, LH; van Rhee, AM | 1 |
| Ash, K; Grohmann, K; Manthey, CL; Manthey, JA; Montanari, A | 1 |
| Brun, R; Lack, G; Perozzo, R; Rüedi, P; Scapozza, L; Tasdemir, D | 1 |
| Akamatsu, M; Hosoda, A; Hotta, Y; Ishimoto, Y; Nishizaki, Y; Tamura, H; Yoshikawa, H | 1 |
| Cho, SJ; Choi, CH; Gadhe, CG; Kothandan, G; Madhavan, T | 1 |
| Duerksen-Hughes, PJ; Filippova, M; Krstenansky, JL; Tungteakkhun, SS; Yuan, CH | 1 |
| Batuta, S; Begum, NA; Das, S; Mitra, I; Niharul Alam, M; Roy, K | 1 |
| Bicknell, KA; Farrimond, JA; Putnam, SE; Swioklo, S; Watson, KA; Williamson, EM | 1 |
| Abramić, M; Agić, D; Bešlo, D; Brkić, H; Karačić, Z; Lisjak, M; Špoljarević, M; Tomić, S | 1 |
| Kang, Y; Kim, BG; Kim, S; Lee, Y; Yoon, Y | 1 |
| Dutour, R; Poirier, D | 1 |
| Jin, YS | 1 |
| Fernandes, E; Fernandes, PA; Freitas, M; Oliveira, A; Proença, C; Ramos, MJ; Ribeiro, D; Silva, AMS; Sousa, JLC | 1 |
| Dai, R; Friedman, FK; Vestal, RE; Wei, X; Zhai, S | 1 |
| Chaudhuri, SK; Kinst-Hori, I; Kubo, I; Kubo, Y; Ogura, T; Sánchez, Y | 1 |
3 review(s) available for flavone and galangin
| Article | Year |
|---|---|
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Protein-Tyrosine Kinases | 1992 |
Inhibitors of cytochrome P450 (CYP) 1B1.
Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship | 2017 |
Recent advances in natural antifungal flavonoids and their derivatives.
Topics: Antifungal Agents; Biological Products; Flavonoids; Fungi; Humans; Mycoses | 2019 |
18 other study(ies) available for flavone and galangin
| Article | Year |
|---|---|
Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
Topics: DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Electrophoresis, Agar Gel; Flavonoids; Hydroxylation; Plasmids; Protein Conformation; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1995 |
Anti-AIDS agents, 10. Acacetin-7-O-beta-D-galactopyranoside, an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some related flavonoids.
Topics: Antiviral Agents; Cells, Cultured; Flavonoids; Galactosides; HIV-1; Humans; Mass Spectrometry; Medicine, Chinese Traditional; Plants, Medicinal; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Virus Replication; Zidovudine | 1994 |
Interactions of flavonoids and other phytochemicals with adenosine receptors.
Topics: Animals; Cell Line; CHO Cells; Cricetinae; Flavonoids; Humans; Magnetic Resonance Spectroscopy; Plants; Protein Binding; Radioligand Assay; Rats; Receptors, Purinergic P1 | 1996 |
Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists.
Topics: Animals; Brain Chemistry; CHO Cells; Cricetinae; Drug Design; Flavonoids; Humans; Kinetics; Molecular Structure; Nerve Tissue Proteins; Protein Binding; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Receptor, Adenosine A2A; Receptors, Purinergic P1; Recombinant Fusion Proteins; Structure-Activity Relationship | 1996 |
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
Topics: Amino Acid Sequence; Blood Coagulation; Cell Adhesion; Endotoxins; Flavonoids; Humans; In Vitro Techniques; Interleukin-1; Molecular Sequence Data; Monocytes | 1996 |
Flavonoid derivatives as adenosine receptor antagonists: a comparison of the hypothetical receptor binding site based on a comparative molecular field analysis model.
Topics: Binding Sites; Computer Simulation; Flavonoids; Kinetics; Least-Squares Analysis; Models, Molecular; Molecular Conformation; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A3; Receptors, Purinergic P1; Regression Analysis; Reproducibility of Results; Static Electricity; Structure-Activity Relationship | 1998 |
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
Topics: Citrus; Cyclic AMP; Flavonoids; Humans; In Vitro Techniques; Lipopolysaccharides; Monocytes; Phosphodiesterase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 1999 |
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase; Alcohol Oxidoreductases; Animals; Antimalarials; Catechin; Cells, Cultured; Chloroquine; Drug Resistance; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Fatty Acids; Flavones; Flavonoids; Humans; Hydro-Lyases; Kinetics; Luteolin; Phenols; Plasmodium falciparum; Polyphenols; Structure-Activity Relationship | 2006 |
Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.
Topics: Androgen Receptor Antagonists; Androgens; Cell Line, Tumor; Flavonoids; Genes, Reporter; Humans; Receptors, Androgen; Receptors, Glucocorticoid; Structure-Activity Relationship | 2009 |
Docking and 3D-QSAR (quantitative structure activity relationship) studies of flavones, the potent inhibitors of p-glycoprotein targeting the nucleotide binding domain.
Topics: Amino Acid Sequence; ATP Binding Cassette Transporter, Subfamily B; Binding Sites; Flavones; Humans; Models, Molecular; Molecular Sequence Data; Nucleotides; Quantitative Structure-Activity Relationship; Sequence Homology, Amino Acid | 2011 |
Small molecule inhibitors of the HPV16-E6 interaction with caspase 8.
Topics: Apoptosis; Caspase 8; Caspase Inhibitors; Fas-Associated Death Domain Protein; Female; Flavones; Flavonols; Host-Pathogen Interactions; Human papillomavirus 16; Humans; Oncogene Proteins, Viral; Papillomavirus Infections; Repressor Proteins; Small Molecule Libraries; Uterine Cervical Neoplasms | 2012 |
Design, synthesis and exploring the quantitative structure-activity relationship of some antioxidant flavonoid analogues.
Topics: Antioxidants; Drug Design; Flavonoids; Quantitative Structure-Activity Relationship | 2014 |
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
Topics: Cell Differentiation; Flavonoids; Humans; Mesenchymal Stem Cells; Molecular Structure; Osteogenesis; Signal Transduction; Structure-Activity Relationship | 2015 |
Validation of flavonoids as potential dipeptidyl peptidase III inhibitors: Experimental and computational approach.
Topics: Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Flavonoids; Humans; Hydrophobic and Hydrophilic Interactions; Molecular Dynamics Simulation; Principal Component Analysis; Protease Inhibitors; Quantitative Structure-Activity Relationship | 2017 |
Inhibitory potential of flavonoids on PtdIns(3,4,5)P3 binding with the phosphoinositide-dependent kinase 1 pleckstrin homology domain.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Binding Sites; Flavones; Flavonoids; Flavonols; Liposomes; Molecular Docking Simulation; Phosphatidylinositol Phosphates; Pleckstrin Homology Domains; Protein Binding; Quantitative Structure-Activity Relationship | 2017 |
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
Topics: Drug Design; Enzyme Inhibitors; Flavonoids; Fructose; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Liver; Molecular Structure | 2020 |
Inhibition of methoxyresorufin demethylase activity by flavonoids in human liver microsomes.
Topics: Adult; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Female; Flavones; Flavonoids; Humans; Isoenzymes; Microsomes, Liver; Oxidoreductases | 1998 |
Flavonols from Heterotheca inuloides: tyrosinase inhibitory activity and structural criteria.
Topics: Arnica; Binding Sites; Catechol Oxidase; Chelating Agents; Copper; Enzyme Inhibitors; Flavanones; Flavones; Flavonoids; Flavonols; Fungal Proteins; Inhibitory Concentration 50; Kaempferols; Kinetics; Levodopa; Monophenol Monooxygenase; Oxidation-Reduction; Plant Extracts; Plants, Medicinal; Quercetin; Spectrophotometry; Structure-Activity Relationship | 2000 |